VYNE Therapeutics
VYNE
#9889
Rank
A$39.24 M
Marketcap
$2.58
Share price
-6.59%
Change (1 day)
-40.00%
Change (1 year)

Earnings for VYNE Therapeutics (VYNE)

Earnings in 2024 (TTM): -A$66.32 Million

According to VYNE Therapeutics's latest financial reports the company's current earnings are A$0.5 Million. a decrease over its 2023 earnings that were of -A$48.4 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for VYNE Therapeutics from 2017 to 2024

Annual earnings

Year Earnings Change
2024 -A$72.18 Million49.14%
2023 -A$48.4 Million-14.09%
2022 -A$56.34 Million-19.38%
2021 -A$69.88 Million-83.2%
2020 -A$0.42 Billion229.89%
2019 -A$0.13 Billion39.8%
2018 -A$90.21 Million84.29%
2017 -A$48.95 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-A$0.24 Billion 227.46%๐Ÿ‡บ๐Ÿ‡ธ USA